Screener
Ocular Therapeutix OCUL Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by Ocular Therapeutix in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.
The source filing: Ocular Therapeutix’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 7:28 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-055256
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $666,699 | $737,060 |
| Accounts receivable, net | 24,347 | 30,650 |
| Inventory | 3,737 | 3,564 |
| Prepaid expenses and other current assets | 11,212 | 10,855 |
| Total current assets | 705,995 | 782,129 |
| Property and equipment, net | 18,425 | 19,676 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Ocular Therapeutix's accounts receivable?
- Ocular Therapeutix (OCUL) reported accounts receivable of $24.35M in Q1 2026.
- How has Ocular Therapeutix's accounts receivable changed year-over-year?
- Ocular Therapeutix's accounts receivable decreased by 3.5% year-over-year, from $25.22M to $24.35M.
- What is the long-term trend for Ocular Therapeutix's accounts receivable?
- Over 5 years (2020 to 2025), Ocular Therapeutix's accounts receivable has grown at a 20.1% compound annual growth rate (CAGR), from $12.25M to $30.65M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.
Ask your AI about Ocular Therapeutix's accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude